Age is an issue of mind over matter — h/t Mark Twain — but early ALS clinical trial results from Google-backed aging-disease ...

Alphabet is the mother company of Google. Google’s (GOOGL) anti-aging company Calico released disappointing trial results of its first ever drug. Calico’s fosigotifator was tested for amyotrophic ...

Google’s ageing therapeutics and research company Calico has bolstered its computational research offerings with the latest big name appointment in the pharma industry. Daphne Koller ...

Calico, Google 's anti-aging subsidiary, has announced disappointing results from its first-ever drug trial. The experimental ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. It's the first ...

The collaboration with Google sister company Calico – formed in 2014 with $1.5 billion in funding and extended in 2018 with another $1 billion top up – has already resulted in three clinical ...

Calico doesn't make a lot of visa hires ... Alphabet has two investment arms: CapitalG (formerly known as Google Capital) and GV (formerly Google Ventures). While they make big bets, they're ...

Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the ...

In studies by Massachusetts General Hospital, the AbbVie-Calico collaborative drug and Denali Therapeutics' own drug failed to meet endpoints for treating amyotrophic lateral sclerosis, more widely ...

Arthur Levinson, the CEO of Calico, Google's project to improve human longevity. Levinson rose through the ranks at biotech pioneer Genentech to become its CEO from 1995 through 2009, and Chairman ...

STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup.